HER2‐positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab‐based chemotherapy: A case report

Abstract This case highlights the rare entity, salivary duct carcinoma (SDC), which is difficult to diagnose and manage. It is the first published case of a metastatic, HER2‐positive parotid SDC successfully treated by a dual anti‐HER2 treatment associated to a chemotherapy.

Bibliographic Details
Main Authors: Raffaele Longo, Pierre‐Olivier Legros, Marouane Talbi, Marc Wagner, Elena‐Adinisia Paraschiv, Marco Campitiello, Francesca Plastino, Antonio Rozzi
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.3209